Blog
10 Articles
![A latex-gloved hand doing close lab work](https://letswinpc.org/wp-content/uploads/2022/09/ct2019mar5.jpg)
Targeting Cancer-Associated Wasting With Experimental Immunotherapy
Wasting, or cachexia, is the focus of a clinical trial testing a cachexia immunotherapy treatment combined with standard pancreatic cancer treatment.
![Chemistry test tubes that are capped and filled with yellow and pink liquids, laying flat on a dark blue table](https://letswinpc.org/wp-content/uploads/2022/09/ct2017oct20.jpg)
Novel Drug Combination Plus Radiation for Locally Advanced Pancreatic Cancer
A clinical trial combines immunotherapy, common treatments, an antiretroviral drug, and SBRT for locally advanced pancreatic cancer.
![Pancreas cross section embedded in paraffin wax, stained blue and purple, 100x magnification.](https://letswinpc.org/wp-content/uploads/2022/09/ct2017jan16.jpg)
Comparing a Standard Chemotherapy With and Without a PARP Inhibitor
A clinical trial compares standard chemotherapy with and without the addition of a PARP inihibitor, for patients whose pancreatic cancer is spreading again.
![Four transparent oblong orange pills and five round white pills on an orange background](https://letswinpc.org/wp-content/uploads/2022/09/ct2016oct31.jpg)
Using a Vitamin to Make Low-Dose Chemotherapy More Effective
A clinical trial compares the effectiveness of low-dose continuous chemotherapy with and without high doses of vitamin C.
![microscope image of pancreatic cancer--the blue irregular circles on the left--and normal pancreas cells--the smaller circles on the right](https://letswinpc.org/wp-content/uploads/2022/09/ct2016jun3.jpg)
Low-Dose Continuous Chemotherapy as Part of a New Combination of Drugs
A clinical trial uses a new immunotherapy drug in combination with standard chemotherapy drugs in metronomic therapy to treat metastatic pancreatic cancer.
![lab cylinders, beakers, glass bottles upside down on a drying rack](https://letswinpc.org/wp-content/uploads/2022/10/tubes-on-rack-nci-vol-3893-150-e1477592371124.jpg)
Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.